Outcomes of MPN patients versus non-MPN patients hospitalized for COVID-19

COVID-19 and MPN updatesПодробнее

6th Annual Canadian MPN Patient Conference - Part 1Подробнее

MPN Specialist discusses COVID-19 and the Johns Hopkins ExperienceПодробнее

COVID-19 and MPNПодробнее

Coronavirus and myeloproliferative neoplasms MPNsПодробнее

COVID-19 occurrence and impact in hematological oncology patientsПодробнее

COVID-19 patterns in patients with MPNs in the first versus second wavesПодробнее

Risks and outcomes of COVID-19 infection for patients on immunotherapyПодробнее

Assessing COVID-19 infection rates in patients with AML and MPNПодробнее

What Patients Should Know About Developing MPN Treatments and ResearchПодробнее

Improving outcomes for MPNПодробнее

Key Questions to Ask When Considering an MPN Clinical TrialПодробнее

Improving outcomes for MPNПодробнее

What needs to be considered in patients with MPN with COVID-19?Подробнее

What are the long-term effects of COVID-19 in patients with MPN?Подробнее

Improving Outcomes for Hospitalized Patients with COVID-19Подробнее

Conversation with MPN Specialists: Focus on MyelofibrosisПодробнее

MPNs and COVID-19Подробнее

Tracking MPN Symptoms: Strategies for Managing Disease BurdenПодробнее